Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 472

1.
2.

Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.

Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A.

Ophthalmology. 2001 Feb;108(2):331-7.

PMID:
11158809
3.

Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.

Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE, Rosenthal A.

Am J Ophthalmol. 1999 Mar;127(3):253-9.

PMID:
10088733
4.

Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.

Simone JN, Pendelton RA, Jenkins JE.

J Cataract Refract Surg. 1999 May;25(5):699-704.

PMID:
10330648
5.

Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.

Brint SF, Cheetham JK, DeGryse R, Abel ML, Thompson VM, Rosenthal A.

J Cataract Refract Surg. 1999 Jan;25(1):41-9.

PMID:
9888075
6.
7.

Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.

Solomon KD, Donnenfeld ED, Raizman M, Sandoval HP, Stern K, VanDenburgh A, Cheetham JK, Schiffman R; Ketorolac Reformulation Study Groups 1 and 2.

J Cataract Refract Surg. 2004 Aug;30(8):1653-60.

PMID:
15313287
9.
10.

Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. Ketorolac Study Group.

Rajpal RK, Cooperman BB.

J Refract Surg. 1999 Nov-Dec;15(6):661-7.

PMID:
10590004
11.
12.

Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.

Hirneiss C, Neubauer AS, Kampik A, Schönfeld CL.

Graefes Arch Clin Exp Ophthalmol. 2005 Aug;243(8):768-73. Epub 2005 Mar 9.

PMID:
15756571
13.
14.

Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.

Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T.

J Cataract Refract Surg. 2006 Sep;32(9):1474-82.

PMID:
16931258
15.

Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.

Heier JS, Topping TM, Baumann W, Dirks MS, Chern S.

Ophthalmology. 2000 Nov;107(11):2034-8;discussion 2039.

PMID:
11054327
16.

A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.

Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M; Acular LS for Cystoid Macular Edema (ACME) Study Group.

Am J Ophthalmol. 2008 Oct;146(4):554-560. doi: 10.1016/j.ajo.2008.04.036. Epub 2008 Jul 2.

PMID:
18599019
18.

Efficacy of preoperative versus postoperative ketorolac tromethamine 0.5% in reducing inflammation after cataract surgery.

El-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ.

J Cataract Refract Surg. 2000 Nov;26(11):1626-30.

PMID:
11084270
19.
20.

Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.

Maca SM, Amon M, Findl O, Kahraman G, Barisani-Asenbauer T.

Am J Ophthalmol. 2010 May;149(5):777-84. doi: 10.1016/j.ajo.2009.12.010. Epub 2010 Feb 11.

PMID:
20152959

Supplemental Content

Support Center